Semaglutide arrived decades later, a GLP-1 receptor agonist that mimics a gut hormone your body already produces, working through entirely different pathways to reduce hunger, slow gastric emptying, and rewire how your brain responds to food
GLP-1 therapy is not a standalone solution and is used as part of a comprehensive medical weight loss program
Potential benefits of GLP-1s under investigation Beyond diabetes and weight loss, researchers are exploring other potential benefits of GLP-1 drugs
If the patient does not tolerate a specific dose during the dose escalation period, consider delaying the dose escalation for 4 weeks
Observational studies show that people with diabetes using GLP1 therapies tend to have lower rates of dementia compared to those on other treatments
Many people notice a reduced desire for sugary foods, late night snacking, or emotional eating